Claus-Henning Köhne
Klinikum Oldenburg(DE)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer(2009)3,836 cited
- → Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status(2011)1,880 cited
- → Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer(2015)790 cited
- → 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial(2013)500 cited
- → Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group(2007)276 cited
- → Randomized, Placebo-Controlled, Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal Adenocarcinoma(2011)161 cited
- → ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016(2016)127 cited
- → Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001(2008)101 cited
- → Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial(2013)90 cited
- → Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials(2011)77 cited